BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21744470)

  • 1. Is tumor biopsy necessary?
    Müllhaupt B; Durand F; Roskams T; Dutkowski P; Heim M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S14-25. PubMed ID: 21744470
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?
    Olthoff KM; Forner A; Hübscher S; Fung J
    Liver Transpl; 2011 Oct; 17 Suppl 2():S26-33. PubMed ID: 21656653
    [No Abstract]   [Full Text] [Related]  

  • 3. Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.
    Kneteman N; Livraghi T; Madoff D; de Santibañez E; Kew M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S117-27. PubMed ID: 21584926
    [No Abstract]   [Full Text] [Related]  

  • 4. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
    Yao FY; Breitenstein S; Broelsch CE; Dufour JF; Sherman M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S109-16. PubMed ID: 21584927
    [No Abstract]   [Full Text] [Related]  

  • 5. Is the treatment of hepatocellular carcinoma on the waiting list necessary?
    Majno P; Lencioni R; Mornex F; Girard N; Poon RT; Cherqui D
    Liver Transpl; 2011 Oct; 17 Suppl 2():S98-108. PubMed ID: 21954097
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatocellular cancer with a background of liver cirrhosis].
    Zhuravlev VA; Agalakov VI
    Klin Med (Mosk); 1996; 74(2):2-5. PubMed ID: 8772088
    [No Abstract]   [Full Text] [Related]  

  • 7. Should we perform deceased donor liver transplantation after living donor liver transplantation has failed?
    Greig PD; Geier A; D'Alessandro AM; Campbell M; Wright L
    Liver Transpl; 2011 Oct; 17 Suppl 2():S139-46. PubMed ID: 21563294
    [No Abstract]   [Full Text] [Related]  

  • 8. Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries?
    Audet M; Panaro F; Piardi T; Wolf P
    Liver Transpl; 2009 Jul; 15(7):822-3; author reply 824-6. PubMed ID: 19562722
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver transplantation for hepatocellular carcinoma: the best treatment, but for which patient?
    Schwartz ME
    Hepatology; 1996 Dec; 24(6):1539-41. PubMed ID: 8938193
    [No Abstract]   [Full Text] [Related]  

  • 10. Imaging diagnosis and staging of hepatocellular carcinoma.
    Lee JM; Trevisani F; Vilgrain V; Wald C
    Liver Transpl; 2011 Oct; 17 Suppl 2():S34-43. PubMed ID: 21739567
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver transplantation for hepatocellular carcinoma without preoperative tumor biopsy.
    Compagnon P; Grandadam S; Lorho R; Turlin B; Camus C; Jianrong Y; Lainé F; Meunier B; Deugnier Y; Boudjema K
    Transplantation; 2008 Oct; 86(8):1068-76. PubMed ID: 18946344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
    Davis E; Wiesner R; Valdecasas J; Kita Y; Rossi M; Schwartz M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S162-6. PubMed ID: 21688382
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular carcinoma and liver transplantation.
    Washburn K; Halff G
    Curr Opin Organ Transplant; 2011 Jun; 16(3):297-300. PubMed ID: 21505342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
    Stock PG; Fung J
    Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
    [No Abstract]   [Full Text] [Related]  

  • 15. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.
    Mazzaferro V; Bhoori S; Sposito C; Bongini M; Langer M; Miceli R; Mariani L
    Liver Transpl; 2011 Oct; 17 Suppl 2():S44-57. PubMed ID: 21695773
    [No Abstract]   [Full Text] [Related]  

  • 16. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?
    Grant D; Fisher RA; Abecassis M; McCaughan G; Wright L; Fan ST
    Liver Transpl; 2011 Oct; 17 Suppl 2():S133-8. PubMed ID: 21634006
    [No Abstract]   [Full Text] [Related]  

  • 17. Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement.
    Prasad KR; Young RS; Burra P; Zheng SS; Mazzaferro V; Moon DB; Freeman RB
    Liver Transpl; 2011 Oct; 17 Suppl 2():S81-9. PubMed ID: 21748847
    [No Abstract]   [Full Text] [Related]  

  • 18. Selection of candidates with HCC for transplantation in the MELD era.
    Sala M; Varela M; Bruix J
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S4-9. PubMed ID: 15382217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2010 International Consensus Conference on Liver Transplantation for Hepatocellular Carcinoma: texts of experts.
    Lesurtel M; Clavien PA
    Liver Transpl; 2011 Oct; 17 Suppl 2():S1-5. PubMed ID: 21656651
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
    Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
    Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.